Showing 1 - 10 of 16
Countries with larger increases in the share of cardiovascular drug doses that contained post-1990 or post-1995 ingredients had smaller increases in the cardiovascular disease hospital discharge rate, controlling for the quantity of cardiovascular medications consumed per person, the use of...
Persistent link: https://www.econbiz.de/10012464639
This paper examines whether there are complementarities between investments in ICT, R&D and organizational innovation … return of 9.7%, followed by 6% to 7% on organizational innovation and a modest 1.4% to 1.8% on R&D in services and …
Persistent link: https://www.econbiz.de/10012480697
I analyze the effects of four types of medical innovation and cancer incidence on U.S. cancer mortality rates during …Under the assumption that there were no pre-dated factors that drove both innovation and mortality and that there would … have been parallel trends in mortality in the absence of innovation, the estimates indicate that there were three major …
Persistent link: https://www.econbiz.de/10012462770
After presenting the history, the evolution and the content of innovation surveys, we discuss the characteristics of … have been made of these data: the construction of scoreboards for monitoring innovation and the scholarly analysis of … various issue related to innovation. In particular we review the questions examined and the results obtained regarding the …
Persistent link: https://www.econbiz.de/10012462793
We examine the impact of pharmaceutical innovation on the longevity of Australians during the period 1995-2003. Due to …
Persistent link: https://www.econbiz.de/10012464638
the elasticity of innovation with respect to the expected price of drugs should be at least as great as the elasticity of … innovation with respect to expected market size (disease incidence). I examine the cross-sectional relationship between … pharmaceutical innovation and market size among a set of diseases (different types of cancer) exhibiting substantial exogenous …
Persistent link: https://www.econbiz.de/10012466126
This paper proposes a framework to account for innovation similar to the usual accounting framework in production … analysis and a measure of innovativity comparable to that of total factor productivity. This innovation accounting framework is … illustrated using micro-aggregated firm data from the first Community Innovation Surveys (CIS1) for seven European countries …
Persistent link: https://www.econbiz.de/10012466388
higher rates of lab and outpatient innovation had greater declines in the probability of missing work during 1996-2003. This … for initial disability, the inverse relationship between lab innovation and disability changes disappears. This is because … there is a significant inverse relationship between initial health and the extent of laboratory innovation. But due to …
Persistent link: https://www.econbiz.de/10012466549
This paper compares the contribution of R&D to innovation in terms of the various innovation output measures provided … by the third Community Innovation Survey (CIS 3) for French manufacturing firms and in terms of accounting for inter …-industry innovation differences …
Persistent link: https://www.econbiz.de/10012467790
We perform an econometric analysis of the effect of new drug launches on longevity, using data from the IMS Health Drug Launches database and the WHO Mortality Database. Our data cover virtually all of the diseases borne by people in 52 countries during the period 1982-2001, and enable us to...
Persistent link: https://www.econbiz.de/10012468944